NO971136L - Aminoalkyl- og acylaminoalkyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister - Google Patents

Aminoalkyl- og acylaminoalkyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister

Info

Publication number
NO971136L
NO971136L NO971136A NO971136A NO971136L NO 971136 L NO971136 L NO 971136L NO 971136 A NO971136 A NO 971136A NO 971136 A NO971136 A NO 971136A NO 971136 L NO971136 L NO 971136L
Authority
NO
Norway
Prior art keywords
aminoalkyl
acylaminoalkyl
ether
preparation
receptor antagonists
Prior art date
Application number
NO971136A
Other languages
English (en)
Norwegian (no)
Other versions
NO971136D0 (no
Inventor
Holger Heitsch
Adalbert Wagner
Klaus Wirth
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO971136D0 publication Critical patent/NO971136D0/no
Publication of NO971136L publication Critical patent/NO971136L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO971136A 1996-03-13 1997-03-12 Aminoalkyl- og acylaminoalkyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister NO971136L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19609827A DE19609827A1 (de) 1996-03-13 1996-03-13 Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten

Publications (2)

Publication Number Publication Date
NO971136D0 NO971136D0 (no) 1997-03-12
NO971136L true NO971136L (no) 1997-09-15

Family

ID=7788139

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971136A NO971136L (no) 1996-03-13 1997-03-12 Aminoalkyl- og acylaminoalkyleter, fremgangsmåte for fremstilling derav og anvendelse som bradykinin-reseptor antagonister

Country Status (26)

Country Link
US (1) US6140341A (cs)
EP (1) EP0795547B1 (cs)
JP (1) JP4317597B2 (cs)
KR (1) KR970065521A (cs)
AR (1) AR006189A1 (cs)
AT (1) ATE192738T1 (cs)
AU (1) AU1621797A (cs)
BR (1) BR9701267A (cs)
CA (1) CA2199771A1 (cs)
CZ (1) CZ76697A3 (cs)
DE (2) DE19609827A1 (cs)
DK (1) DK0795547T3 (cs)
ES (1) ES2148858T3 (cs)
GR (1) GR3033415T3 (cs)
HR (1) HRP970138A2 (cs)
HU (1) HUP9700566A1 (cs)
ID (1) ID16217A (cs)
IL (1) IL120427A0 (cs)
NO (1) NO971136L (cs)
PL (1) PL318923A1 (cs)
PT (1) PT795547E (cs)
SI (1) SI0795547T1 (cs)
SK (1) SK32097A3 (cs)
TR (1) TR199700184A2 (cs)
TW (1) TW363891B (cs)
ZA (1) ZA972129B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
AR070950A1 (es) 2007-11-01 2010-05-19 Acucela Inc Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos
SMT202200154T1 (it) 2017-11-24 2022-05-12 Pharvaris Netherlands B V Nuovi antagonisti del recettore della bradichinina b2
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
KR20240039185A (ko) 2021-08-05 2024-03-26 파르바리스 게엠베하 브래디키닌 b2-수용체 길항제의 경구 투여용 지질 기반 조성물
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
HRP20260166T1 (hr) 2022-03-25 2026-03-27 Pharvaris Gmbh Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5288725A (en) * 1992-10-15 1994-02-22 Merck & Co., Inc. Pyrroloquinoline Bradykinin antagonist
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
CN1168667A (zh) * 1994-10-27 1997-12-24 藤沢药品工业株式会社 用作缓激肽拮抗剂的吡啶并嘧啶酮,喹啉和稠合的n-杂环化合物
FR2735128B1 (fr) * 1995-06-07 1997-07-25 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique.
FR2737892B1 (fr) * 1995-08-17 1997-10-24 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
CA2199771A1 (en) 1997-09-13
KR970065521A (ko) 1997-10-13
ES2148858T3 (es) 2000-10-16
MX9701857A (es) 1997-09-30
NO971136D0 (no) 1997-03-12
HRP970138A2 (en) 1998-04-30
ATE192738T1 (de) 2000-05-15
EP0795547A1 (de) 1997-09-17
US6140341A (en) 2000-10-31
JPH101472A (ja) 1998-01-06
SI0795547T1 (en) 2000-10-31
AU1621797A (en) 1997-09-18
PL318923A1 (en) 1997-09-15
PT795547E (pt) 2000-10-31
DK0795547T3 (da) 2000-09-18
EP0795547B1 (de) 2000-05-10
GR3033415T3 (en) 2000-09-29
DE19609827A1 (de) 1997-09-18
DE59701617D1 (de) 2000-06-15
HUP9700566A1 (hu) 2000-08-28
SK32097A3 (en) 1998-01-14
ID16217A (id) 1997-09-11
HU9700566D0 (en) 1997-04-28
AR006189A1 (es) 1999-08-11
CZ76697A3 (en) 1997-10-15
BR9701267A (pt) 1999-01-12
TR199700184A2 (xx) 1997-10-21
IL120427A0 (en) 1997-07-13
JP4317597B2 (ja) 2009-08-19
ZA972129B (en) 1997-09-15
TW363891B (en) 1999-07-11

Similar Documents

Publication Publication Date Title
HRP20000182B1 (en) Processes and intermediates for preparing anti-cancer compounds
EA200001135A1 (ru) Способ получения изоксазолин-3-ил-ацилбензолов
TW363891B (en) Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor
PL378201A1 (pl) Sposób farmaceutyczny oraz związki wytwarzane tym sposobem
AU554976B2 (en) 1-phenyl-2-aminocarbonylindole compounds
EP2393779A2 (en) Process for the synthesis of cleistanthin
EA200000484A1 (ru) Способ получения производных тиазолидиндиона
CA1055032A (en) Process for the preparation of thieno (3,2-c) pyridine and thieno (2,3-c) pyridine
ES8606228A1 (es) Un procedimiento para separar los antipodas opticos de 1-pi-ridil-alquil-4-aril-piperazinas
DE3468104D1 (en) New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use
Atkins et al. Pseudohalogen chemistry. XI. Some aspects of the chemistry of α-thiocyanato-β-dicarbonyl compounds
El‐Deen Use of 3–(2′‐formyl‐1′‐chlorovinyl) coumarin in the syntheses of pyrazol, salicylaldazine and pyrimidine derivatives
Sharma et al. Studies on Fused. BETA.-Lactams: Synthesis of 1-Aza Analogs of Cephem.
Tasaka et al. Synthesis of 2‐phenylimidazo [2, 1‐b] benzothiazole derivatives as modulators of multidrug resistance for tumor cells
RO83468B (ro) Procedeu de obtinere a derivatilor de 5, 6, 7, 7a-tetrahidro-4h-tieno(3, 2-c)-piridin-2-onei
Tamura et al. Mono‐N‐amino salt of benzodiazines and naphthyridines
SU640663A3 (ru) Способ получени производных нитрохиназолинона
Dunn et al. Sulphur Analogues of Deoxyvasicinone
Wang et al. A Novel Synthesis of Thieno [2, 3-C] pyrazole
CA1193255A (en) Benzylazone derivatives
SE8502973D0 (sv) Framstellning av aminderivat
JPS5470277A (en) Hydroxyindole derivatives
GR70255B (cs)
ES8201532A1 (es) Procedimiento de preparacion de derivados de fenil alcoxi propanolaminas
Corsaro et al. A CONVENIENT SYNTHESIS OF 2-ALKYL-and 2-ARYLAMINO-4-ARYL-5-CYA